<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   3788
  </number>
  <updateDate>
   2023-03-08T19:58:55Z
  </updateDate>
  <updateDateIncludingText>
   2023-03-08T19:58:55Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-06-08
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 99 (Tuesday, June 8, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. NUNES:H.R. 3788.Congress has the power to enact this legislation pursuantto the following:Clause 1 of section 8 of article I of the Constitution ofthe United States.[Page H2702]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hswm04
      </systemCode>
      <name>
       Trade Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-06-08T20:41:55Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-08T14:08:40Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsru00
    </systemCode>
    <name>
     Rules Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-08T14:08:45Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Protecting American Innovation Act
    </title>
    <congress>
     117
    </congress>
    <number>
     7430
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2022-04-06
     </actionDate>
     <text>
      Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-06-08
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm04
      </systemCode>
      <name>
       Trade Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Trade.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-06-08
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsru00
      </systemCode>
      <name>
       Rules Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-08
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-08
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-06-08
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     N000181
    </bioguideId>
    <fullName>
     Rep. Nunes, Devin [R-CA-22]
    </fullName>
    <firstName>
     Devin
    </firstName>
    <lastName>
     Nunes
    </lastName>
    <party>
     R
    </party>
    <state>
     CA
    </state>
    <district>
     22
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <policyArea>
   <name>
    Foreign Trade and International Finance
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Asia
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      China
     </name>
    </item>
    <item>
     <name>
      Competitiveness, trade promotion, trade deficits
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Employee performance
     </name>
    </item>
    <item>
     <name>
      Europe
     </name>
    </item>
    <item>
     <name>
      Federal officials
     </name>
    </item>
    <item>
     <name>
      Foreign aid and international relief
     </name>
    </item>
    <item>
     <name>
      Government ethics and transparency, public corruption
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Intellectual property
     </name>
    </item>
    <item>
     <name>
      Legislative rules and procedure
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Presidents and presidential powers, Vice Presidents
     </name>
    </item>
    <item>
     <name>
      Public participation and lobbying
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
    <item>
     <name>
      Russia
     </name>
    </item>
    <item>
     <name>
      Trade agreements and negotiations
     </name>
    </item>
    <item>
     <name>
      World health
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Foreign Trade and International Finance
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-06-08
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2022-04-20T19:12:44Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;Protecting American Innovation Act&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill establishes certain limitations on modifying trade agreements, including those related to the TRIPS Agreement (i.e., the Agreement on Trade-Related Aspects of Intellectual Property Rights). The TRIPS Agreement contains obligations for World Trade Organization members to protect patents and other intellectual property rights.&lt;/p&gt; &lt;p&gt;Specifically, the bill prohibits the President (or any U.S. official, employee, or agent) from negotiating or concluding any withdrawal, suspension, or modification to a trade agreement that adversely affects the rights of the United States or U.S. persons under a trade agreement with China or Russia.&lt;/p&gt; &lt;p&gt;Additionally, the bill states that a TRIPS waiver to address the COVID-19 pandemic shall not take effect if (1) the President does not submit required reports from the Department of Commerce and the Department of Defense (DOD), (2) the Commerce report concludes that the TRIPS waiver will not result in an increase in global vaccine access, or (3) the DOD report concludes that the TRIPS waiver would adversely impact U.S. national security.&lt;/p&gt; &lt;p&gt;Prior to entering into a negotiation with a trading partner concerning a suspension of or modification to a trade agreement, the bill requires (1) the U.S. Trade Representative to publish certain information in the Federal Register and allow for public comment, and (2) the President to provide written notice and consult with Congress. Further, the President shall not enter into any suspension of or modification to a trade agreement unless the President has complied with such consultation requirements and receives congressional approval.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Protecting American Innovation Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Protecting American Innovation Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To establish limitations on modifications to trade agreements, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Protecting American Innovation Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-06-08T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr3788ih/xml/BILLS-117hr3788ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-06-08
   </actionDate>
   <text>
    Referred to the Subcommittee on Trade.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-06-08
Trade Subcommittee
hswm04
1
House committee actions
Referred to the Subcommittee on Trade.
Committee
H11100
2021-06-08
Rules Committee
hsru00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-08
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-08
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-08
9
Library of Congress
Introduced in House
IntroReferral
2021-06-08T14:08:40Z
Referred to
House
Ways and Means Committee
2021-06-08T20:41:55Z
Referred to
Trade Subcommittee
hswm04
hswm00
Standing
2021-06-08T14:08:45Z
Referred to
House
Rules Committee
hsru00
Standing
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-06-08
2021-06-08
Referred to the Subcommittee on Trade.
House
Foreign Trade and International Finance
2022-04-06
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
CRS
Identical bill
Protecting American Innovation Act
HR
N000181
22
Devin
Rep. Nunes, Devin [R-CA-22]
N
Nunes
R
CA
Asia Cardiovascular and respiratory health China Competitiveness, trade promotion, trade deficits Congressional oversight Emergency medical services and trauma care Employee performance Europe Federal officials Foreign aid and international relief Government ethics and transparency, public corruption Government information and archives Government studies and investigations Health care coverage and access Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Legislative rules and procedure Manufacturing Medical research Presidents and presidential powers, Vice Presidents Public participation and lobbying Research and development Russia Trade agreements and negotiations World health
2021-06-08
Introduced in House
 <p><strong>Protecting American Innovation Act</strong></p> <p>This bill establishes certain limitations on modifying trade agreements, including those related to the TRIPS Agreement (i.e., the Agreement on Trade-Related Aspects of Intellectual Property Rights). The TRIPS Agreement contains obligations for World Trade Organization members to protect patents and other intellectual property rights.</p> <p>Specifically, the bill prohibits the President (or any U.S. official, employee, or agent) from negotiating or concluding any withdrawal, suspension, or modification to a trade agreement that adversely affects the rights of the United States or U.S. persons under a trade agreement with China or Russia.</p> <p>Additionally, the bill states that a TRIPS waiver to address the COVID-19 pandemic shall not take effect if (1) the President does not submit required reports from the Department of Commerce and the Department of Defense (DOD), (2) the Commerce report concludes that the TRIPS waiver will not result in an increase in global vaccine access, or (3) the DOD report concludes that the TRIPS waiver would adversely impact U.S. national security.</p> <p>Prior to entering into a negotiation with a trading partner concerning a suspension of or modification to a trade agreement, the bill requires (1) the U.S. Trade Representative to publish certain information in the Federal Register and allow for public comment, and (2) the President to provide written notice and consult with Congress. Further, the President shall not enter into any suspension of or modification to a trade agreement unless the President has complied with such consultation requirements and receives congressional approval.</p>
2022-04-20T19:12:44Z
00
2021-06-08T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr3788ih/xml/BILLS-117hr3788ih.xml
Protecting American Innovation Act
Protecting American Innovation Act
Display Title
IH
Introduced in House
To establish limitations on modifications to trade agreements, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Protecting American Innovation Act
Short Title(s) as Introduced
HR
2023-03-08T19:58:55Z
2023-03-08T19:58:55Z
3.0.0
2022-04-06
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
CRS
Identical bill
Protecting American Innovation Act
HR
2021-06-08
Trade Subcommittee
hswm04
1
House committee actions
Referred to the Subcommittee on Trade.
Committee
H11100
2021-06-08
Rules Committee
hsru00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-08
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-08
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-08
9
Library of Congress
Introduced in House
IntroReferral
N000181
22
Devin
Rep. Nunes, Devin [R-CA-22]
N
Nunes
R
CA
Asia Cardiovascular and respiratory health China Competitiveness, trade promotion, trade deficits Congressional oversight Emergency medical services and trauma care Employee performance Europe Federal officials Foreign aid and international relief Government ethics and transparency, public corruption Government information and archives Government studies and investigations Health care coverage and access Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Legislative rules and procedure Manufacturing Medical research Presidents and presidential powers, Vice Presidents Public participation and lobbying Research and development Russia Trade agreements and negotiations World health
2021-06-08
Introduced in House
 <p><strong>Protecting American Innovation Act</strong></p> <p>This bill establishes certain limitations on modifying trade agreements, including those related to the TRIPS Agreement (i.e., the Agreement on Trade-Related Aspects of Intellectual Property Rights). The TRIPS Agreement contains obligations for World Trade Organization members to protect patents and other intellectual property rights.</p> <p>Specifically, the bill prohibits the President (or any U.S. official, employee, or agent) from negotiating or concluding any withdrawal, suspension, or modification to a trade agreement that adversely affects the rights of the United States or U.S. persons under a trade agreement with China or Russia.</p> <p>Additionally, the bill states that a TRIPS waiver to address the COVID-19 pandemic shall not take effect if (1) the President does not submit required reports from the Department of Commerce and the Department of Defense (DOD), (2) the Commerce report concludes that the TRIPS waiver will not result in an increase in global vaccine access, or (3) the DOD report concludes that the TRIPS waiver would adversely impact U.S. national security.</p> <p>Prior to entering into a negotiation with a trading partner concerning a suspension of or modification to a trade agreement, the bill requires (1) the U.S. Trade Representative to publish certain information in the Federal Register and allow for public comment, and (2) the President to provide written notice and consult with Congress. Further, the President shall not enter into any suspension of or modification to a trade agreement unless the President has complied with such consultation requirements and receives congressional approval.</p>
2022-04-20T19:12:44Z
00
Protecting American Innovation Act
Protecting American Innovation Act
Display Title
IH
Introduced in House
To establish limitations on modifications to trade agreements, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Protecting American Innovation Act
Short Title(s) as Introduced
2021-06-08
Referred to the Subcommittee on Trade.